QQQ   443.97 (-0.19%)
AAPL   171.41 (-1.10%)
MSFT   420.72 (-0.17%)
META   485.90 (-1.61%)
GOOGL   150.80 (-0.05%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.05%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   443.97 (-0.19%)
AAPL   171.41 (-1.10%)
MSFT   420.72 (-0.17%)
META   485.90 (-1.61%)
GOOGL   150.80 (-0.05%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.05%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   443.97 (-0.19%)
AAPL   171.41 (-1.10%)
MSFT   420.72 (-0.17%)
META   485.90 (-1.61%)
GOOGL   150.80 (-0.05%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.05%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   443.97 (-0.19%)
AAPL   171.41 (-1.10%)
MSFT   420.72 (-0.17%)
META   485.90 (-1.61%)
GOOGL   150.80 (-0.05%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.05%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
NYSEARCA:XBI

SPDR S&P Biotech ETF (XBI) Price, Holdings, & News

$94.92
+0.01 (+0.01%)
(As of 04:00 PM ET)
Today's Range
$94.06
$95.89
50-Day Range
$87.06
$102.93
52-Week Range
$63.80
$103.52
Volume
10.15 million shs
Average Volume
11.73 million shs
Market Capitalization
$7.28 billion
Assets Under Management
$7.54 billion
Dividend Yield
N/A
Net Expense Ratio
0.35%
XBI stock logo

About SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

XBI Stock Price History

XBI ETF News Headlines

2 Top Biotech Buyout Candidates
3 Biotech Stocks to Buy on the Dip: March 2024
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
3 Biotech ETFs Overdue for a Bounce
Heard on the Street Recap: Zooming Up
Spdr S&P Biotech Etf
XBI ETF Stock Price History
AI to Meet the Same Fate as EVs?
When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11…
SPDR S&P Biotech ETF (XBI)
See More Headlines
Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Biotech ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:XBI
Inception Date
1/31/2006
Fund Manager
Michael Feehily, Karl Schneider, Raymond Donofrio

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotech Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
139

Fund Statistics

Assets Under Management
$7.54 billion
Average Daily Volume
$12.48 million
Discount/Premium
-0.02%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
84,766
Put Options
62,166
Call Options
22,600
Short Interest
53,580,000 shs

Miscellaneous

Beta
0.97
Creation Unit
50,000
Creation Fee
$250.00
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

SPDR S&P Biotech ETF Expenses

TypeXBIHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.57%0.54%0.50%0.51%
Other Expenses0.00%0.40%0.54%0.64%0.58%
Total Expense0.35%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.53%-0.54%-0.69%-0.56%
Net Expense0.35%0.61%0.60%0.57%0.58%

SPDR S&P Biotech ETF (XBI) Holdings & Exposure

Key Executives

  • James E. Ross (Age 52)
    President, Trustee
  • Peter A. Ambrosini (Age 69)
    Chief Compliance Officer
  • Michael P. Riley (Age 44)
    Vice President
  • Gary L. French (Age 64)
    Treasurer
  • John W. Clark (Age 46)
    Assistant Treasurer
  • Matthew W. Flaherty (Age 42)
    Assistant Treasurer
  • Chad C. Hallett (Age 47)
    Assistant Treasurer of Street tracks series trust
  • Mary Moran Zeven (Age 52)
    Secretary
  • Scott M. Zoltowski (Age 44)
    Assistant Secretary
  • Dave Kelly
    Independent Trustee

XBI ETF - Frequently Asked Questions

How have XBI shares performed in 2024?

SPDR S&P Biotech ETF's stock was trading at $89.29 on January 1st, 2024. Since then, XBI shares have increased by 7.0% and is now trading at $95.51.
View the best growth stocks for 2024 here
.

What does XBI invest in?

SPDR S&P Biotech ETF is a equity fund issued by SSgA. XBI focuses on health care investments and follows the S&P Biotech Index. The fund's investments total to approximately $7.54 billion assets under management.

What is the management fee for SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for XBI is 0.35%.

What other stocks do shareholders of SPDR S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Biotechnology ETF (IBB), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

Who are SPDR S&P Biotech ETF's major shareholders?

SPDR S&P Biotech ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Citadel Advisors LLC (0.00%), Avoro Capital Advisors LLC (5.79%), Nantahala Capital Management LLC (0.00%), Goldman Sachs Group Inc. (0.00%), Healthcare of Ontario Pension Plan Trust Fund (3.14%) and Healthcare of Ontario Pension Plan Trust Fund (3.14%).

How do I buy shares of SPDR S&P Biotech ETF?

Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:XBI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners